Bladder cancer diagnostics company Pacific Edge has announced a $20 million capital raising alongside a half-year loss as its US market breakthrough remains elusive.
At balance date, Pacific Edge had cash and short-term deposits of $4.7m, a sum well below its operating cashflow in the six months
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
